Cooperative Agreement U48DP006883
Award Date
9/30/24
Completion Date
9/29/29
Dollars Obligated
$1M
Funding Federal Agency
National Center for Immunization and Respiratory Diseases
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.323
Assistance Type
Cooperative Agreement
Place of Performance
United States
Similar Awards
The federal Cooperative Agreement award NU51CK000343, funded by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323), provides $1,830,778 to the Massachusetts Department of Public Health (MDPH) to enhance the state's public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases. The ELC program supports a range of activities including epidemiological...
The University of Massachusetts Medical School (UMass Medical) was awarded a $2,000,000 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) program. This award, with an effective date of September 30, 2024 and a completion date of September 29, 2029, will support UMass Medical's Prevention Research Center in conducting research, interventions, and public health awareness initiatives...
The University of Massachusetts Medical School (UMass Medical) was awarded a $900,000.00 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) federal grant program. The award, with a performance period from September 30, 2024 to September 29, 2029, will support research, intervention, and awareness initiatives related to chronic disease prevention and management. As a prominent...
The Centers for Disease Control and Prevention (CDC) awarded a $799,904 Cooperative Agreement to New York University School of Medicine under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The award, which runs from September 30, 2024 to September 29, 2029, supports activities to enhance public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases. Key products and services to be delivered include...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $3,978,670.00 Cooperative Agreement to the Human Services Vermont Agency Of under the Epidemiology and Laboratory Capacity (ELC) program (CFDA 93.283) from August 1, 2024 to July 31, 2029. The ELC program supports public health initiatives to control communicable diseases, chronic diseases, and other preventable health conditions through research, surveillance, epidemiological investigations, and laboratory capacity building. As...
This is a federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The $1,499,856 award to the University of Rochester, valid from Sep 30, 2024 to Sep 29, 2027, will support the "Trusted School Messengers Promoting Non-Mandated Vaccination" project. The project aims to enhance public health infrastructure for detecting, responding to, preventing,...
This Cooperative Agreement award, valued at $2,618,602.00, was granted by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The award supports North Carolina's efforts to enhance epidemiological surveillance, laboratory testing capabilities, and interdisciplinary collaboration for detecting, responding to, preventing, and controlling infectious disease threats. Key activities include...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $899,809 Cooperative Agreement to Medical Care Development Inc. (MCD), a non-profit public health institute in Hallowell, Maine, under the CDC Collaboration with Academia to Strengthen Public Health program (CFDA 93.967). This 5-year award (August 1, 2024 to July 31, 2029) supports MCD in strengthening public health infrastructure, workforce capabilities, and data systems across the state of Maine. Specifically, the...
This federal Cooperative Agreement award, valued at $1,050,000.00 and awarded by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323), is supporting the University of Arizona in conducting community-based participatory research to enhance vaccine uptake across the lifespan through innovative points of access and altering norms in border and rural regions. The award, with a performance period from...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $2,250,000 Cooperative Agreement to the Massachusetts Department of Public Health (MDPH) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The funding will support MDPH's efforts to assess disproportionate exposure to environmental chemicals among communities in Massachusetts. The 3-year award, running from September 1, 2024 to August 31, 2027, will enable MDPH to conduct biomonitoring activities,...